{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:46:20Z","timestamp":1789782380175,"version":"4.0.1"},"reference-count":84,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T00:00:00Z","timestamp":1279152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:p>Lower limb disorders of movement and muscle tone in adults significantly impact quality of life. The management of the patient with hypertonia is complex and requires a multidisciplinary team working with the patient and family\/carers. Botulinum neurotoxin type A (BoNT\u2010A) has been used as a component of this management to reduce lower limb hypertonia, increase passive range of motion and reduce associated pain and requirements for bracing. Adjunctive treatments to augment the effect of BoNT\u2010A include electrical muscle stimulation of the injected muscles and stretching. When determining suitability for injection, the patient\u2019s main goals for intervention need to be established. Muscle overactivity must be distinguished from contracture, and the effect of underlying muscle weakness taken into account. Explanation of the injection process, potential adverse effects and post\u2010injection interventions is essential. Assessment at baseline and post\u2010treatment of impairments such as hypertonia, range of motion and muscle spasm are appropriate; however, the Goal Attainment Scale and other validated patient\u2010centred scales can also be useful to assess therapy outcomes. In the future, initiatives should be directed towards examining the effectiveness of BoNT treatment to assist with achievement of functional and participation goals in adults with hypertonia and dystonia affecting the lower limb.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2010.03128.x","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T11:48:06Z","timestamp":1279194486000},"page":"57-73","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement"],"prefix":"10.1111","volume":"17","author":[{"given":"J.","family":"Olver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Esquenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. S. C.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. J.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7,15]]},"reference":[{"key":"e_1_2_9_2_2","unstructured":"American Academy of Neurology (AAN).AAN classification of evidence for therapeutic intervention. Available online:http:\/\/www.aan.com\/go\/practice\/guidelines."},{"issue":"2","key":"e_1_2_9_3_2","first-page":"3","article-title":"International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments","volume":"17","author":"Esquenazi A","year":"2010","journal-title":"Eur J Neurol"},{"key":"e_1_2_9_4_2","unstructured":"World Health Organization.International Classification of Functioning Disability and Health (ICF).2001. Available online:http:\/\/www.who.int\/classifications\/icf\/en\/."},{"key":"e_1_2_9_5_2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ptj\/82.11.1098","article-title":"Use of the ICF model as a clinical problem\u2010solving tool in physical therapy and rehabilitation medicine","volume":"82","author":"Steiner WA","year":"2002","journal-title":"Phys Ther"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9993(93)90119-U"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2004.11.008"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/0269905031000149498"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.516153"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199303000-00006"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-0272"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269215509103551"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269215508101742"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/0013188960380204"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/13638490500235581"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/09638280701618828"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/38.6.735"},{"key":"e_1_2_9_18_2","first-page":"540","article-title":"Preliminary trial of carisoprodal in multiple sclerosis","volume":"192","author":"Ashworth B","year":"1964","journal-title":"Practitioner"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/67.2.206"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.61.3.265"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000069495"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9993(98)90068-5"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2003.08.081"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-005-0378-9"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.01.009"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.phm.0000223216.50068.bc"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.phm.0000193505.85874.61"},{"key":"e_1_2_9_28_2","first-page":"87","article-title":"Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke","volume":"23","author":"Farina S","year":"2008","journal-title":"Funct Neurol"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2007.08.131"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaitpost.2008.07.005"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0b013e318168d36c"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.69.4.499"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.6.707"},{"key":"e_1_2_9_34_2","first-page":"277","article-title":"Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults \u2013 preliminary report","volume":"9","author":"Opara J","year":"2007","journal-title":"Ortop Traumatol Rehabil"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002060-199811000-00012"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.2.232"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9993(96)90015-5"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-9651(03)00093-7"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280407"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.0090s1048.x"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.4.712"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.65.762.208"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.27.3.455"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1191\/0269215505cr827oa"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002060-200210000-00009"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2005.06.008"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.1999.tb00032.x"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2008.04.030"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2007.10.022"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9993(03)00014-5"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-0303"},{"key":"e_1_2_9_52_2","first-page":"93","volume-title":"Therapy with Botulinum Toxin","author":"Hatherway CG","year":"1994"},{"key":"e_1_2_9_53_2","volume-title":"Spasticity in Adults: Management Using Botulinum Toxin. National Guidelines","author":"Royal College of Physicians","year":"2009"},{"key":"e_1_2_9_54_2","volume-title":"The Upper Motor Neuron Syndrome and Muscle Overactivity including Spasticity and the Role of Botulinum Toxin. We Move","author":"Mayer N","year":"2008"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0b013e3181a5b056"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511544842.003"},{"key":"e_1_2_9_57_2","first-page":"113","volume-title":"Spasticity: Diagnosis and Management","author":"Esquenazi A","year":"2010"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/359832a0"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(93)90077-X"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.6.3200"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269215507072772"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0b013e318168ceaf"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01617.x"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1080\/16501970500415348"},{"key":"e_1_2_9_65_2","first-page":"837","article-title":"[Safety and tolerance of single\u2010dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group]","volume":"111","author":"Wissel J","year":"1999","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-0251"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)12124-9"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120115"},{"key":"e_1_2_9_69_2","first-page":"183","volume-title":"Treatment of Movement Disorders","author":"Brin MF","year":"1995"},{"key":"e_1_2_9_70_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.4.616"},{"key":"e_1_2_9_71_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1984.01040031184014"},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92070-2"},{"key":"e_1_2_9_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20794"},{"key":"e_1_2_9_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00887828"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21396"},{"key":"e_1_2_9_76_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000172930.63669.c8"},{"key":"e_1_2_9_77_2","first-page":"CR282","article-title":"Botulinum toxin type B for gait freezing in Parkinson\u2019s disease","volume":"10","author":"Fernandez HH","year":"2004","journal-title":"Med Sci Monit"},{"key":"e_1_2_9_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100317"},{"key":"e_1_2_9_79_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10382"},{"key":"e_1_2_9_80_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2006000600028"},{"key":"e_1_2_9_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.08.013"},{"key":"e_1_2_9_82_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001199-200511000-00007"},{"key":"e_1_2_9_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01652.x"},{"key":"e_1_2_9_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2006.02.015"},{"key":"e_1_2_9_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.04.015"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2010.03128.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2010.03128.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T12:49:15Z","timestamp":1694609355000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2010.03128.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,15]]},"references-count":84,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1468-1331.2010.03128.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03128.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,15]]},"assertion":[{"value":"2010-07-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}